Using exosomes from engineered heart tissues to repair damaged hearts
Nanowired humam cardiac organoid derived exosomes for heart repair
This study is exploring how tiny particles called exosomes, which come from cells, can help heal heart damage from heart attacks by using special 3D models of heart cells, aiming to improve treatment for people with heart injuries.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Clemson University NIH-funded |
| Lab location | 1 site (Clemson, United States) |
| Project ID | NIH-11055371 on NIH RePORTER |
What this research studies
This research investigates the use of exosomes, which are tiny particles released by cells, to treat heart damage caused by acute infarction. By creating 3D cultures of human heart cells, the researchers aim to enhance the production of these exosomes, which carry important signals that can help repair heart tissue. The study focuses on developing nanowired human cardiac organoids that mimic heart tissue more closely than traditional 2D cultures, potentially leading to better outcomes for patients with heart injuries.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who have experienced acute heart infarction or have heart failure.
Not a fit: Patients with chronic heart conditions unrelated to acute infarction may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapies that significantly improve heart repair and recovery for patients suffering from heart failure.
How similar studies have performed: Previous research has shown promise in using exosome therapies for heart repair, indicating that this approach could be a significant advancement in cardiac treatment.
Where this research is happening
Clemson, United States
- Clemson University — Clemson, United States (Active)
Researchers
- Principal investigator: Mei, Ying — Clemson University
- Study coordinator: Mei, Ying
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.